azacitidine and Adenocarcinoma, Basal Cell

azacitidine has been researched along with Adenocarcinoma, Basal Cell in 127 studies

Research

Studies (127)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (4.72)	18.7374
1990's	16 (12.60)	18.2507
2000's	61 (48.03)	29.6817
2010's	41 (32.28)	24.3611
2020's	3 (2.36)	2.80

Authors

Authors	Studies
Ahuja, N; Azad, NS; Baretti, M; Cope, L; Durham, JN; Heumann, TR; Leatherman, J; Linden, S; Lopez-Vidal, TY; Monga, DK; O'Dwyer, PJ; Reiss, KA; Sharma, A; Sugar, EA; Weekes, CD	1
Borlak, J; Liu, L; Tang, Z	1
Hosseinpourfeizi, MA; Moaddab, Y; Rezaei, S; Safaralizadeh, R	1
Deng, X; Hou, C; Liang, T; Wang, H; Zhu, L	1
Gabius, HJ; Gebert, J; Katzenmaier, EM; Kloor, M; Kopitz, J	1
Ambs, S; Calin, GA; Croce, CM; Esposito, D; Hudson, RS; Liu, CG; Prueitt, RL; Schetter, AJ; Stephens, RM; Van Roosbroeck, K; Volfovsky, N; Volinia, S; Yi, M	1
Arneth, BM; Fuessel, S; Hagelgans, A; Menschikowski, M; Nacke, B; Siegert, G; Wirth, MP	1
Arai, E; Betsuyaku, T; Kanai, Y; Kohno, T; Sato, T; Soejima, K; Tsuta, K; Watanabe, S	1
Peek, RM; Schneider, BG	1
Mori, A; Niwa, T; Tatematsu, M; Toyoda, T; Tsukamoto, T; Ushijima, T	1
Cheng, Y; Dong, M; Fan, X; Feng, X; Jin, Z; Meltzer, SJ; Mori, Y; Wang, L; Zhang, X; Zhao, Z	1
Cao, Z; Chen, S; Cheng, Y; Dong, M; Fan, X; Feng, X; Gao, Y; Jin, Z; Liu, J; Meltzer, SJ; Mori, Y; Wang, L; Yu, H; Zhang, X; Zhang, Y; Zhao, Z	1
Cui, W; Huang, HQ; Li, N; Zhang, GS	1
Berdel, WE; Dugas, M; Haase, AK; Hascher, A; Hebestreit, K; Jungen, D; Klein, HU; Müller-Tidow, C; Ogawa, S; Rius, M; Rohde, C; Schulze, I; Stoll, M; Thoennissen, NH; Tickenbrock, L; Wiewrodt, R; Witten, A	1
Cheng, Y; Dang, C; Diao, D; Guo, Q; Liu, D; Song, Y; Wang, W; Wu, X; Xia, P; Zhang, H	1
Baylin, SS; Belinsky, SA; Liu, Y; Tellez, CS; Tessema, M; Van Neste, L; Yingling, CM	1
Chen, H; Chu, Y; Dowdy, SC; Jiang, SW; Li, J; Liu, F; Wang, Y; Xiong, Y; Zhang, G; Zhang, R	1
Chen, L; Huang, G; Ren, J; Song, H; Wang, R	1
Cao, Z; Chen, S; Cheng, Y; Dong, M; Fan, X; Feng, X; Gao, Y; Jin, Z; Liu, J; Meltzer, SJ; Mori, Y; Wang, L; Wu, W; Yu, H; Zhang, X; Zhao, Z	1
Aguila, B; Duan, W; Gao, L; Kalvala, A; Otterson, GA; Reese, T; Villalona-Calero, MA	1
Ahrens, TD; Boerries, M; Busch, H; Follo, M; Hembach, S; Hoeppner, J; Hopt, UT; Lassmann, S; Ostendorp, J; Timme, S; Werner, M	1
Choi, JH; Kim, GJ; Kim, HS; Kim, J; Kim, N; Lee, HJ; Lee, JO; Lee, SK; Lee, YW; Moon, JW; Park, SH; Seo, JS	1
Dong, Y; Ji, T; Liang, J; Ma, Z; Xiao, Y; Yin, G	1
Gao, B; Li, GH; Shao, GG; Yang, B; Yang, ZG	1
Chen, J; Gao, J; Gu, X; Liu, T; Lü, L; Mei, Z; Zeng, H	1
Du, Z; Feng, X; Lai, Q; Li, A; Liu, B; Song, J; Sun, X; Wang, H; Xu, Y	1
Akizuki, R; Endo, S; Hichino, A; Ikari, A; Matsunaga, T; Okamoto, M; Taga, S	1
Califano, JA; Henrique, R; Jeronimo, C; Kim, MS; Lee, J; Liu, JW; Moon, CS; Nagpal, JK; Ostrow, KL; Sidransky, D; Sun, W; Trink, B; Van Criekinge, W; Zhou, S	1
Chen, H; El-Rifai, W; Peng, DF; Razvi, M; Roessner, A; Schneider-Stock, R; Washington, K	1
Abraham, JM; Agarwal, R; Beer, DG; Cheng, Y; David, S; Hamilton, JP; Ito, T; Jin, Z; Kan, T; Meltzer, SJ; Mori, Y; Olaru, A; Paun, B; Sato, F; Selaru, FM; Shimada, Y; Yang, J	1
Albertus, DL; Beer, DG; Bigbee, WL; Chang, AC; Chen, G; Chinnaiyan, AM; Giordano, TJ; Hartojo, W; Lin, L; Orringer, MB; Seder, CW; Silvers, A; Thomas, DG; Wang, X	1
Hou, K; Hu, X; Jing, W; Liu, Y; Qu, X; Teng, Y; Yang, X; Zhang, J; Zhang, Y	1
Foster, BA; Karpf, AR; Mavis, CK; Morey Kinney, SR	1
Billam, M; Davidson, NE; Sobolewski, MD	1
Chen, Y; Collins, C; Huo, D; Nwachukwu, C; Olopade, OI; Rowell, J; Slamon, DJ; Xu, J	1
Akashi, H; Igarashi, S; Imai, K; Issa, JP; Itoh, F; Kai, M; Maruyama, R; Nojima, M; Sasaki, Y; Shen, L; Shinomura, Y; Sugai, T; Suzuki, H; Tokino, T; Toyota, M; Watanabe, Y; Yamamoto, E; Yamamoto, H	1
Costanzo, C; Dandrea, M; Donadelli, M; Palmieri, M; Scarpa, A	1
Gutkin, DW; Shurin, GV; Shurin, MR; Song, EY; Tourkova, IL	1
Ishii, J; Kashiwagi, K; Kitamura, H; Masuda, M; Mitsui, H; Ogura, T; Ohmori, T; Okudela, K; Oshiro, H; Sakaeda, M; Sato, H; Shimoyamada, H; Suzuki, T; Tajiri, M; Woo, T; Yazawa, T	1
El-Rifai, W; Hu, T; Jackson, K; Marshal, D; Peng, D; Soutto, M	1
Adachi, Y; Hizaki, K; Imai, K; Kato, N; Nakazawa, M; Sanchez, JV; Sasaki, S; Shinomura, Y; Sukawa, Y; Suzuki, H; Taniguchi, H; Tanuma, T; Yamamoto, H	1
Al-Sohaily, S; Cooper, WA; Kennedy, CW; Kohonen-Corish, MR; McCaughan, BC; Mladenova, DN; Pangon, L; Selinger, CI; Stirzaker, C	1
Chen, HM; Du, W; Fang, JY; Hong, J; Tang, JT; Wang, JL; Wang, YC; Xiong, H; Zhao, SL	1
El-Rifai, W; Hu, TL; Jiang, A; Moskaluk, CA; Peng, D; Schneider-Stock, R; Washington, MK	1
Cronk, RJ; Lang, JM; McNeel, DG; Smith, HA	1
Akahira, J; Hiroki, E; Ito, K; Miki, Y; Nagase, S; Sasano, H; Sugawara, J; Suzuki, F; Suzuki, T; Yaegashi, N	1
Chang, YL; Hong, TM; Jou, YS; Lin, JC; Lin, TC; Wu, CT; Wu, JY; Wu, YY; Yang, PC	1
Cogdill, AP; Cooper, ZA; Ferrone, CR; Fiedler, A; Frederick, DT; Garber, HR; Rosenberg, L; Thayer, SP; Wargo, JA; Warshaw, AL	1
Cornfield, DB	1
Aoki, D; Banno, K; Kisu, I; Kobayashi, Y; Masuda, K; Nomura, H; Susumu, N; Tominaga, E; Tsuji, K; Ueki, A; Yamagami, W; Yanokura, M	1
Jiang, GY; Li, QC; Wang, EH; Xu, HT; Xu, K; Yang, LH; Zhang, XP; Zhao, HY	1
Fukuyama, Y; Gazdar, AF; Minna, JD; Tockman, MS; Toyooka, S; Wistuba, II	1
Chen, Z; Cheng, X; Wu, Y; Zhu, B	1
Deng, G; Han, SW; Ho, JJ; Kim, YS; Kuan, SF; Pan, PL	1
Goggins, M; Maehara, N; Sato, N; Su, GH	1
Durkin, ME; Popescu, NC; Yuan, BZ	1
Chan, AW; Chan, MW; Chan, PK; Lee, TL; Lo, KW; To, KF; Tong, JH; Yu, MY	1
Brune, K; Fukushima, N; Goggins, M; Hruban, RH; Matsubayashi, H; Sahin, F; Sato, N; Walter, KM; Yeo, CJ	1
Borczuk, AC; Brody, JS; Busch, S; Capurro, M; D'Armiento, JM; Filmus, J; Kim, H; Lange, J; Powell, CA; Rothman, PB; Xu, GL	1
Casey, G; Issa, JP; Kasturi, L; Li, H; Lutterbaugh, J; Markowitz, SD; Myeroff, L; Plass, C; Pretlow, TP; Rerko, RM; Romero, MF; Smiraglia, D; Willis, J; Willson, JK	1
Chan, AS; Chan, TL; Chen, X; Chu, KM; Leung, SY; Li, R; So, S; Tsui, WY; Yuen, ST	1
Chow, BK; Lee, LT; Ng, SS; Pang, RT; Yung, WH	1
Honoki, K; Mii, Y; Mori, T; Takakura, Y; Tsujiuchi, T; Tsutsumi, M; Yoshitani, K	1
Alder, H; Aqeilan, RI; Cesari, R; Croce, CM; Kanematsu, T; Kuroki, T; Matsuyama, A; Mori, M; Nolli, ML; Rattan, S; Trapasso, F; Williams, NN; Yendamuri, S	1
Logsdon, CD; Okami, J; Simeone, DM	1
Eshleman, JR; Fukushima, N; Goggins, M; Iacobuzio-Donahue, CA; Miyagi, Y; Parker, AR; Sato, N	1
Chen, J; Ebert, MP; Götze, T; Klein-Hitpass, L; Leodolter, A; Malfertheiner, P; Röcken, C	1
Furukawa, T; Horii, A; Kanai, N; Sunamura, M; Xu, S	1
Abe, T; Chang, R; Dhara, S; Goggins, M; Hustinx, SR; Maitra, A; Martin, ST; Sato, N	1
Dowdy, SC; Eberhardt, NL; Gonzalez Bosquet, J; Jiang, SW; Podratz, KC; Xiong, Y; Zhao, Y	1
Aung, PP; Kawahara, K; Kuraoka, K; Nakayama, H; Noguchi, T; Oue, N; Shutoh, M; Yasui, W	1
Benhattar, J; Bosman, FT; Braunschweig, R; Clément, G; Pasquier, N	1
Bae, HI; Kim, DS; Kim, MJ; Kim, SG; Lee, JY; Lee, YM; Park, JY	1
Hu, L; Huang, G; Sun, D; Tang, A; Van, do N; Zhang, Z	1
Carvalho, AL; Cerveira, N; Costa, VL; Henrique, R; Hoque, MO; Jerónimo, C; Oliveira, J; Ribeiro, FR; Sidransky, D; Teixeira, MR	1
Fields, CR; Pan, YX; Robertson, KD; Su, N; Zhong, S	1
Abraham, JM; Cheng, Y; Greenwald, BD; Hamilton, JP; Ito, T; Jin, Z; Kan, T; Meltzer, SJ; Mori, Y; Paun, BC; Sato, F; Wang, S; Yang, J	1
Euhus, DM; Fong, KM; Gao, B; Gazdar, AF; Gerald, W; Girard, L; Jiang, A; Kim, YH; Lam, CL; Lewis, CM; Minna, JD; Nanda, R; Olopade, OI; Perou, CM; Pollack, JR; Sato, M; Shames, DS; Shay, JW; Shivapurkar, N; Shyr, Y; Wong, M	1
Fujisawa, T; Gazdar, AF; Iizasa, T; Minna, JD; Shames, DS; Shigematsu, H; Shivapurkar, N; Sunaga, N; Suzuki, M; Takahashi, T	1
Chen, Y; Deutschmann, N; Knösel, T; Kotb, WF; Lund, P; Pacyna-Gengelbach, M; Petersen, I; Schlüns, K; Sers, C; Usui, T; Yasumoto, H; Ye, F	1
Beckhove, P; Buchler, MW; Galindo-Escobedo, LV; Geng, W; Koch, M; Krempien, R; Niethammer, AG; Rimoldi, D; Romero, P; Schmitz-Winnenthal, FH; Weitz, J; Z'graggen, K	1
Day, ML; Gschwend, JE; Kuefer, R; McCabe, MT; Wojno, KJ; Zorn, CS	1
Chen, D; Cheng, L; Gao, L; Lu, ZH; Pan, SY; Shu, YQ; Xie, EF; Yang, D; Zhang, JN; Zhang, LX	1
Bang, YJ; Im, SA; Jong, HS; Jung, Y; Kim, TY; Park, J; Park, JH; Robertson, KD	1
Ekström, L; Gustafsson, O; Morfin, R; Olsson, M; Rane, A; Rietz, BD; Skogastierna, C; Tolf, A	1
Dacic, S; Guo, M; Landreneau, R; Siegfried, JM; Sun, Q; Yu, J; Yue, W; Zhang, L; Zhou, W	1
Akiyoshi, J; Aoki, D; Banno, K; Fujii, T; Hirasawa, A; Iwata, T; Kawaguchi, M; Kobayashi, Y; Kuwabara, Y; Susumu, N; Tsukazaki, K; Yanokura, M	1
Chan, FK; Cheng, YY; Jin, VX; Leung, WK; Li, J; Man, EP; Sung, JJ; Tao, Q; To, KF; Wong, YP; Yu, J	1
Luo, J; Qi, J; Tao, WH; Zhu, YQ	1
Chung, DC; Kawasaki, T; Kirley, SD; Kwon, E; Lauwers, GY; Mino-Kenudson, M; Ogino, S; Park, DY; Rueda, BR; Sakamoto, H; Zukerberg, LR	1
Hosoya, K; McDonell, N; Niwa, T; Shirai, T; Takahashi, S; Tsujino, Y; Ushijima, T; Watanabe, N; Yamashita, S	1
Luo, J; Qi, J; Tao, WH; Zhang, JM; Zhu, YQ	1
Fitzgerald, RC; Gjerset, RA; Huang, Y; Peters, CJ	1
Chahinian, AP; Greenfield, DS; Holland, JF; Ohnuma, T	1
Bianco, AR; Caraglia, M; Correale, P; Genua, G; Leardi, A; Pepe, S; Pinto, A; Tagliaferri, P; Zagonel, V	1
Blessing, JA; Look, KY; Manetta, A	1
Parekh, HK; Simpkins, H	1
Ben-Baruch, N; Cowan, KH; Denicoff, AM; Goldspiel, BR; O'Shaughnessy, JA	1
Côté, S; Momparler, RL	2
Bang, YJ; Choe, KJ; Jung, CW; Kang, SH; Kim, BK; Kim, NK; Koeffler, HP; Lee, KU; Lee, YY; Seo, JY	1
el Yaagoubi, M; Khalid, A; Siest, G; Visvikis, A; Wellman, M	1
Chi, SG; deVere White, RW; Gumerlock, PH; Muenzer, JT	1
Côté, S; Momparler, RL; Sinnett, D	1
Concha, A; Garrido, F; Hortas, ML; Morell, M; Redondo, M; Ruiz-Cabello, F; Serrano, A	1
Nakamura, N; Takenaga, K	1
Byun, DS; Chi, SG; Kang, MJ; Kim, HJ; Park, BJ; Park, JH; Park, JI	1
Bang, YJ; Choi, HH; Jong, HS; Kang, SH; Kim, NK; Kim, WH; Ryu, MH; Song, SH	1
Arapshian, A; Kuppumbatti, YS; Mira-y-Lopez, R	1
Anna, CH; Barrett, JC; Devereux, TR; Foley, JF; Patel, AC; Stockton, PS; Tyson, FL	1
Imai, K; Itoh, F; Kakiuchi, H; Kikuchi, T; Suzuki, H; Toyota, M	1
Ammanamanchi, S; Brattain, MG; Periyasamy, S; Tillekeratne, MP	1
Chen, GA; Fischette, MR; Guo, ZS; Hong, JA; Nguyen, DM; Ohnmacht, GA; Schrump, DS; Weiser, TS	1
Akakura, K; Ichikawa, T; Igarashi, T; Ito, H; Kito, H; Nakayama, T; Sekita, N; Shiraishi, T; Suzuki, H; Toyota, M; Watanabe, M; Yoshie, O	1
Ashida, T; Fujiki, T; Fujiya, M; Honda, M; Kohgo, Y; Saitoh, Y; Tanabe, H; Watari, J	1
Chen, A; Deng, G; Kim, YS; Pong, E	1
Arnold, JM; Chenevix-Trench, G; Cummings, M; Purdie, D	1
Goggins, M; Hruban, RH; Issa, JP; Skinner, H; Toyota, M; Ueki, T; Walter, KM; Yeo, CJ	1
Abbruzzese, JL; Anzai, H; Frost, P	1
Elliott, MS; Gündüz, U; Houghton, JA; Houghton, PJ; Katze, JR; Seubert, PH; Trewyn, RW	1
Casper, ES; Kelsen, DP; Schwartz, GK	1
Brissette, L; Deeley, RG; Elliott, BE; Holden, JJ; Marshall, J; Mudrik, K; Vekemans, M; Xu, W	1
Arundel, CM; Leith, JT	1
Azuma, M; Hayashi, Y; Sato, M; Yanagawa, T; Yoshida, H; Yura, Y	1
Arnold, M; Bosman, P; Carlow, DA; Elliott, BE; Hampton, N; Ivimey, L	1
Abele, R; Bruntsch, U; Clavel, M; Dodion, P; Gundersen, S; Pinedo, HM; Renard, J; Smyth, J; van Glabbeke, M	1
Hahn, RG; Moertel, CG; Reitemeier, RJ; Schutt, AJ	1

Trials

8 trial(s) available for azacitidine and Adenocarcinoma, Basal Cell

Article	Year
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Clinical epigenetics, 2022, 12-03, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azacitidine; DNA Methylation; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms	2022
MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis, 2011, Volume: 32, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Blotting, Western; Cell Movement; Cell Proliferation; Chromatin Immunoprecipitation; Colorectal Neoplasms; CpG Islands; Decitabine; DNA Methylation; DNA Primers; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Immunoenzyme Techniques; Luciferases; Lymphatic Metastasis; Male; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Prognosis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2011
Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Non-Small-Cell Lung; CpG Islands; DNA Methylation; DNA Mutational Analysis; DNA, Neoplasm; Down-Regulation; Epigenesis, Genetic; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoenzyme Techniques; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Membrane Proteins; Nerve Tissue Proteins; Promoter Regions, Genetic; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Proteins; Receptors, Immunologic; Roundabout Proteins; Tumor Cells, Cultured	2007
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study. American journal of clinical oncology, 1995, Volume: 18, Issue:2 Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Female; Humans; Infusions, Intravenous; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome	1995
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer. Investigational new drugs, 1993, Volume: 11, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azacitidine; Colonic Neoplasms; Drugs, Investigational; Female; Humans; Infusions, Intravenous; Male; Middle Aged	1993
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma. Investigational new drugs, 1992, Volume: 10, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Azacitidine; Female; Humans; Infusion Pumps; Male; Middle Aged; Pancreatic Neoplasms	1992
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Clinical Trials as Topic; Decitabine; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasms	1987
Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer. Cancer chemotherapy reports, 1972, Volume: 56, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Blood Cell Count; Blood Platelets; Clinical Trials as Topic; Cytidine; Female; Gastrointestinal Neoplasms; Humans; Leukocyte Count; Male; Middle Aged; Nausea; Triazines; Vomiting	1972

Other Studies

119 other study(ies) available for azacitidine and Adenocarcinoma, Basal Cell

Article	Year
Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas. Clinical epigenetics, 2023, 05-19, Volume: 15, Issue:1 Topics: Adenocarcinoma; Azacitidine; Cell Line, Tumor; Colorectal Neoplasms; Cytidine Deaminase; Decitabine; DNA Methylation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Prospective Studies; Tetrahydrouridine; Tumor Microenvironment; Tumor Suppressor Protein p53	2023
Contribution of DNA methylation and EZH2 in SRBC down-regulation in gastric cancer. Molecular biology reports, 2020, Volume: 47, Issue:8 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Male; Promoter Regions, Genetic; Pyridones; Stomach Neoplasms	2020
Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma. Molecular medicine reports, 2017, Volume: 16, Issue:5 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adult; Aged; Animals; Azacitidine; Cell Line, Tumor; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Down-Regulation; Endometrial Neoplasms; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Mice; Mice, Nude; Middle Aged; Prognosis; Proto-Oncogene Proteins c-myc; Repressor Proteins	2017
Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer. IUBMB life, 2017, Volume: 69, Issue:12 Topics: Acetylation; Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cohort Studies; Colorectal Neoplasms; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Epithelial Cells; Female; Galectins; Histones; Humans; Male; Middle Aged; Neoplasm Staging; Promoter Regions, Genetic; Protein Isoforms	2017
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Molecular cancer, 2013, Feb-14, Volume: 12 Topics: Adenocarcinoma; Aged; Azacitidine; Case-Control Studies; Cell Line, Tumor; Conserved Sequence; Decitabine; Epigenesis, Genetic; Gene Expression; Gene Expression Regulation, Neoplastic; Genome, Human; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Metribolone; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostate; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; RNA, Untranslated; Testosterone Congeners; Transcriptome	2013
Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms. Experimental and molecular pathology, 2013, Volume: 94, Issue:3 Topics: Adenocarcinoma; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; DNA, Neoplasm; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Neoplasm Invasiveness; Plasminogen Activator Inhibitor 1; Prostate; Prostatic Neoplasms; Urokinase-Type Plasminogen Activator	2013
DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PloS one, 2013, Volume: 8, Issue:3 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Azacitidine; DNA Methylation; DNA Probes; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precancerous Conditions; Proportional Hazards Models; RNA, Messenger	2013
Gastric cancer prevention by demethylation. Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:4 Topics: Adenocarcinoma; Animals; Azacitidine; Decitabine; DNA-Cytosine Methylases; Helicobacter Infections; Helicobacter pylori; Male; Stomach Neoplasms	2013
Prevention of Helicobacter pylori-induced gastric cancers in gerbils by a DNA demethylating agent. Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:4 Topics: Adenocarcinoma; Animals; Azacitidine; Carcinogens; Decitabine; Disease Models, Animal; DNA Methylation; DNA-Cytosine Methylases; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Methylnitrosourea; Stomach Neoplasms	2013
Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer. Cancer, 2013, Oct-15, Volume: 119, Issue:20 Topics: Adenocarcinoma; Aged; Antigens, CD; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Decitabine; DNA Methylation; Endoglin; Esophageal Neoplasms; Esophagus; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Prognosis; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; ROC Curve; Tumor Cells, Cultured	2013
MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma. Scientific reports, 2013, Oct-03, Volume: 3 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Azacitidine; Barrett Esophagus; Carcinoma, Squamous Cell; Case-Control Studies; Decitabine; DNA Methylation; Esophageal Neoplasms; Esophagus; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Myelin and Lymphocyte-Associated Proteolipid Proteins; Neoplasm Grading; Prognosis; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; ROC Curve; Tumor Cells, Cultured	2013
Effect of 5- AZn-2 '-deoxycytidine on proliferation of human lung adenocarcinoma cell line A549 in vitro. Asian Pacific journal of tropical medicine, 2013, Volume: 6, Issue:12 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Cell Shape; Decitabine; Humans; Lung Neoplasms; Malondialdehyde; Superoxide Dismutase	2013
DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes. Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Feb-15, Volume: 20, Issue:4 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azacitidine; Binding Sites; Cell Line, Tumor; DNA Methylation; DNA-Cytosine Methylases; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Phenotype; Polycomb-Group Proteins	2014
Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Case-Control Studies; Cell Cycle Proteins; DNA Methylation; Female; Follow-Up Studies; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Polymerase Chain Reaction; Prognosis; Promoter Regions, Genetic; Proteins; Stomach; Stomach Neoplasms; Survival Rate; Tumor Cells, Cultured	2014
Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers. Carcinogenesis, 2014, Volume: 35, Issue:6 Topics: Adenocarcinoma; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Genome-Wide Association Study; Humans; Lung Neoplasms; Promoter Regions, Genetic; Reproducibility of Results; Smoking	2014
Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers. Cellular and molecular life sciences : CMLS, 2014, Volume: 71, Issue:17 Topics: Adenocarcinoma; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; DNA-Binding Proteins; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Methyl-CpG-Binding Protein 2; Neoplasm Proteins; Protein Binding; Protein Interaction Mapping; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Transcription Factors	2014
Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma. Molecular medicine (Cambridge, Mass.), 2014, Apr-08, Volume: 20 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Azacitidine; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Male; Membrane Proteins; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Sulfonamides; Taxoids; Wnt Signaling Pathway; Xenograft Model Antitumor Assays	2014
Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis. BMC cancer, 2014, May-20, Volume: 14 Topics: Adenocarcinoma; Area Under Curve; Azacitidine; Barrett Esophagus; Carcinoma, Squamous Cell; Caveolin 1; Cell Line, Tumor; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; RNA, Messenger; ROC Curve; Time Factors	2014
Overexpression of Rad51C splice variants in colorectal tumors. Oncotarget, 2015, Apr-20, Volume: 6, Issue:11 Topics: Adenocarcinoma; Alternative Splicing; Amino Acid Sequence; Azacitidine; Cell Line, Tumor; Colorectal Neoplasms; DNA Methylation; DNA Repair; DNA-Binding Proteins; DNA, Neoplasm; Exons; Fanconi Anemia Complementation Group D2 Protein; Gene Expression Profiling; Humans; Matched-Pair Analysis; Microsatellite Instability; Molecular Sequence Data; Neoplasm Proteins; Promoter Regions, Genetic; Protein Isoforms; Protein Structure, Tertiary; RNA, Messenger; RNA, Neoplasm	2015
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Epigenetics, 2015, Volume: 10, Issue:5 Topics: Acetylation; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Benzamides; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Survival; Decitabine; Depsipeptides; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Damage; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Pyridines; Transcriptome; Vorinostat	2015
Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma. Cancer genetics, 2015, Volume: 208, Issue:5 Topics: Adenocarcinoma; Aged; Azacitidine; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Decitabine; DNA Methylation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Matrix Metalloproteinase 16; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering	2015
[5-aza-2'-deoxycytidine suppresses the growth of human lung adenocarcinoma cells in nude mouse xenograft models and its effect on methylation status and expression of TFPI-2 gene]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:7 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Proliferation; Decitabine; Disease Models, Animal; DNA Methylation; Gene Expression Regulation, Neoplastic; Glycoproteins; Heterografts; Humans; Lung Neoplasms; Mice; Mice, Nude; Random Allocation; RNA, Messenger	2015
5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:10 Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Azacitidine; Blotting, Western; Cell Line, Tumor; Death-Associated Protein Kinases; DNA Methylation; Drug Resistance, Neoplasm; Flow Cytometry; Gefitinib; Humans; Lung Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinazolines	2015
Aberrant methylation of microRNA-193b in human Barrett's esophagus and esophageal adenocarcinoma. Molecular medicine reports, 2016, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Barrett Esophagus; Biomarkers, Tumor; Cell Line, Tumor; DNA Methylation; Down-Regulation; Esophageal Neoplasms; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Immunohistochemistry; Male; MicroRNAs; Middle Aged; Promoter Regions, Genetic	2016
Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line. International journal of experimental pathology, 2016, Volume: 97, Issue:6 Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Azacitidine; Cell Survival; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; RNA, Messenger	2016
Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. The Journal of biological chemistry, 2017, 02-10, Volume: 292, Issue:6 Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Azacitidine; Butyric Acid; Cell Proliferation; Chromones; Claudin-2; Down-Regulation; Epigenesis, Genetic; Humans; Hydroxamic Acids; Lung Neoplasms; MicroRNAs; Morpholines; Nitriles; RNA, Messenger; Signal Transduction; Sulfones	2017
ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jun-15, Volume: 14, Issue:12 Topics: Adenocarcinoma; Aged; Azacitidine; Base Sequence; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Decitabine; DNA Methylation; DNA Mutational Analysis; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Prostatic Hyperplasia; Prostatic Neoplasms; Tumor Cells, Cultured	2008
DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut, 2009, Volume: 58, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Barrett Esophagus; Cell Transformation, Neoplastic; CpG Islands; Decitabine; Disease Progression; DNA Methylation; DNA, Neoplasm; Down-Regulation; Epigenesis, Genetic; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Glutathione Peroxidase; Glutathione Transferase; Humans; Hydroxamic Acids; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	2009
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. International journal of cancer, 2008, Nov-15, Volume: 123, Issue:10 Topics: Adenocarcinoma; Azacitidine; Base Sequence; Cadherins; Cell Line, Tumor; DNA Methylation; DNA Primers; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors	2008
AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2008, Volume: 3, Issue:11 Topics: Acetylation; Adenocarcinoma; Adipokines; Adult; Aged; Aged, 80 and over; Autoantibodies; Azacitidine; Biomarkers, Tumor; Carrier Proteins; Case-Control Studies; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycoproteins; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured	2008
GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling. Anti-cancer drugs, 2009, Volume: 20, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Azacitidine; Cell Line, Tumor; Cisplatin; CpG Islands; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Enzyme Induction; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Humans; Inactivation, Metabolic; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Transcription, Genetic	2009
Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. The Prostate, 2009, Sep-01, Volume: 69, Issue:12 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Drug Combinations; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutathione S-Transferase pi; Glutathione Transferase; Hydroxamic Acids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Prostate; Prostatic Neoplasms; RNA, Messenger	2009
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast cancer research and treatment, 2010, Volume: 120, Issue:3 Topics: Adenocarcinoma; Apoptosis Regulatory Proteins; Azacitidine; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Chromatin Immunoprecipitation; Cytidine; Cytidine Deaminase; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Neoplasm Proteins; Receptors, Estrogen; S Phase; Tumor Stem Cell Assay; Vorinostat	2010
CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast cancer research and treatment, 2010, Volume: 120, Issue:3 Topics: Adenocarcinoma; Azacitidine; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, BRCA1; Humans; Hydroxamic Acids; Neoplasm Proteins; Promoter Regions, Genetic; Protein Binding; RNA, Messenger; Transcription Factors; Transcription, Genetic	2010
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Carcinogenesis, 2010, Volume: 31, Issue:3 Topics: Adenocarcinoma; Adenoma; Azacitidine; Cell Line, Tumor; Cellular Senescence; Colorectal Neoplasms; Consensus Sequence; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Gene Silencing; Genes, p53; Histones; Humans; Insulin-Like Growth Factor Binding Proteins; Neoplasm Proteins; Phenotype; Proto-Oncogene Proteins B-raf; Recombinant Fusion Proteins; Tumor Stem Cell Assay; Tumor Suppressor Protein p53	2010
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic acids research, 2009, Volume: 37, Issue:20 Topics: Adenocarcinoma; Azacitidine; CCAAT-Enhancer-Binding Protein-alpha; Cell Line, Tumor; Chromatin Immunoprecipitation; Decitabine; DNA; DNA Methylation; Gene Silencing; Humans; Hydroxamic Acids; Interleukin-6; Methyl-CpG-Binding Protein 2; NF-kappa B; Pancreatic Neoplasms	2009
Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. Cancer research, 2010, Jun-01, Volume: 70, Issue:11 Topics: Adenocarcinoma; Azacitidine; Base Sequence; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Sequence Data; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Messenger	2010
Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. The American journal of pathology, 2010, Volume: 177, Issue:1 Topics: Adenocarcinoma; Animals; Azacitidine; Cell Line, Tumor; Decitabine; Early Growth Response Protein 1; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Promoter Regions, Genetic; Repressor Proteins; RNA Interference; Vascular Endothelial Growth Factor A	2010
Epigenetic silencing of somatostatin in gastric cancer. Digestive diseases and sciences, 2011, Volume: 56, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Methylation; Predictive Value of Tests; Reproducibility of Results; RNA, Messenger; Somatostatin; Stomach Neoplasms	2011
Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2011, Volume: 24, Issue:6 Topics: Adenocarcinoma; Adenoma; Antineoplastic Agents, Alkylating; Azacitidine; Caco-2 Cells; Cell Survival; Colonic Neoplasms; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Gene Expression; Gene Silencing; Humans; Hydroxamic Acids; Receptors, Calcium-Sensing; RNA, Messenger; Tissue Array Analysis	2011
Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011, Volume: 6, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatin Immunoprecipitation; Cohort Studies; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Lung Neoplasms; Male; Matrix Attachment Region Binding Proteins; Middle Aged; Neoplasm Staging; Prognosis; Tissue Array Analysis	2011
Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PloS one, 2011, Volume: 6, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; CpG Islands; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Histones; Humans; Lymphatic Metastasis; Metallothionein 3; Middle Aged; Neoplasm Staging; Nerve Tissue Proteins; Promoter Regions, Genetic; Protein Processing, Post-Translational; Repressor Proteins	2011
Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer. Cancer research, 2011, Nov-01, Volume: 71, Issue:21 Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Cancer Vaccines; Cell Line, Tumor; Decitabine; Epitopes; Female; Gene Expression Regulation, Neoplastic; HLA-A2 Antigen; HLA-DR1 Antigen; Humans; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Molecular Targeted Therapy; Multigene Family; Neoplasm Metastasis; Neoplasm Proteins; Prostatic Neoplasms; Repressor Proteins; Sequence Alignment; Sequence Homology, Amino Acid; T-Cell Antigen Receptor Specificity	2011
MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma. International journal of cancer, 2012, Aug-15, Volume: 131, Issue:4 Topics: Adenocarcinoma; Apoptosis; Azacitidine; Cell Cycle; Cell Division; Cell Line, Tumor; Decitabine; DNA Methylation; Endometrial Neoplasms; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Proto-Oncogene Mas; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction	2012
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO molecular medicine, 2012, Volume: 4, Issue:6 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Animals; Antigens, Neoplasm; Azacitidine; Base Sequence; Cell Adhesion Molecules; Cell Line, Tumor; Decitabine; Disease Models, Animal; Epigenesis, Genetic; Female; Gene Expression; Gene Expression Regulation; Gene Silencing; Histocytochemistry; Humans; Immunohistochemistry; Lung Neoplasms; Male; Mice; Middle Aged; Models, Biological; Molecular Sequence Data; Receptor, IGF Type 1; Signal Transduction	2012
Targeting the MAGE A3 antigen in pancreatic cancer. Surgery, 2012, Volume: 152, Issue:3 Suppl 1 Topics: Adenocarcinoma; Antigens, Neoplasm; Azacitidine; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cytokines; Decitabine; Deoxycytidine; DNA Methylation; Gemcitabine; Humans; Hydroxamic Acids; Immunotherapy; Male; Neoplasm Proteins; Pancreas; Pancreatic Neoplasms; Receptors, Antigen, T-Cell; T-Lymphocytes; Testis; Valproic Acid	2012
Erythroblastic sarcoma, an extremely rare variant of myeloid sarcoma. Human pathology, 2012, Volume: 43, Issue:11 Topics: Abnormal Karyotype; Adenocarcinoma; Aged; Azacitidine; Biopsy, Large-Core Needle; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Erythroblasts; Erythropoietin; Fatal Outcome; Humans; Lymph Nodes; Male; Myelodysplastic Syndromes; Rare Diseases; Rectal Neoplasms; Sarcoma, Myeloid	2012
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells. Oncology reports, 2012, Volume: 28, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Exodeoxyribonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; RecQ Helicases; RNA, Small Interfering; Topoisomerase I Inhibitors; Uterine Cervical Neoplasms; Werner Syndrome Helicase	2012
Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:2 Topics: Adenocarcinoma; Axin Protein; Azacitidine; Base Sequence; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Cell Adhesion; Cell Movement; Cell Proliferation; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2013
Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Azacitidine; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Chromosomes, Human, Pair 8; CpG Islands; Decitabine; DNA Modification Methylases; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Loss of Heterozygosity; Lung Neoplasms; Nerve Tissue Proteins; Polymorphism, Single-Stranded Conformational; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Proteins	2002
Induction of TRAG-3 expression in A549 lung adenocarcinoma cell line by 5-aza-2' deoxyazacytidine. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 38, Issue:3 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lung Neoplasms; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2002
Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. International journal of oncology, 2003, Volume: 22, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Azacitidine; Base Sequence; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Mucin 5AC; Mucin-2; Mucins; Neoplasm Invasiveness; Neoplasm Proteins; Pancreas; Pancreatic Neoplasms; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm	2003
Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. Journal of the National Cancer Institute, 2003, Feb-19, Volume: 95, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA, Neoplasm; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinases; Methylation; Neoplasm Invasiveness; Pancreatic Neoplasms; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2003
Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer genetics and cytogenetics, 2003, Jan-15, Volume: 140, Issue:2 Topics: Adenocarcinoma; Azacitidine; Base Sequence; Breast Neoplasms; Carcinoma, Hepatocellular; Colonic Neoplasms; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; GTPase-Activating Proteins; Humans; Liver Neoplasms; Male; Molecular Sequence Data; Neoplasm Proteins; Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Proteins	2003
Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. International journal of cancer, 2003, Jun-10, Volume: 105, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Carcinoma, Squamous Cell; Chromosomes, Human, Pair 3; DNA Methylation; DNA Primers; DNA, Neoplasm; DNA, Viral; Enzyme Inhibitors; Female; Gene Silencing; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tumor Virus Infections; Uterine Cervical Neoplasms	2003
Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:4 Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; Cyclin D2; Cyclins; Decitabine; Digestive System; DNA Methylation; Female; Humans; Male; Middle Aged; Pancreatic Juice; Pancreatic Neoplasms; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transfection	2003
The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:6 Topics: Adenocarcinoma; Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Decitabine; Enzyme Inhibitors; Gene Expression Profiling; Genes, Tumor Suppressor; Glypicans; Humans; Hydroxamic Acids; Lung Neoplasms; Membrane Proteins; Mice; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Respiratory Mucosa; Smoking; Tumor Suppressor Proteins	2003
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proceedings of the National Academy of Sciences of the United States of America, 2003, Jul-08, Volume: 100, Issue:14 Topics: Adenocarcinoma; Adenoma; Azacitidine; Base Sequence; Cation Transport Proteins; Colonic Neoplasms; DNA Methylation; DNA, Neoplasm; Exons; Gene Silencing; Genes, Tumor Suppressor; Humans; Intestinal Mucosa; Ion Transport; Molecular Sequence Data; Monocarboxylic Acid Transporters; Recombinant Fusion Proteins; Sodium; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay	2003
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. Oncogene, 2003, Oct-09, Volume: 22, Issue:44 Topics: Adenocarcinoma; Azacitidine; Cell Line; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Helix-Loop-Helix Motifs; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Inhibitor of Differentiation Proteins; Microsatellite Repeats; Promoter Regions, Genetic; Stomach Neoplasms; Transcription Factors	2003
CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:2 Topics: Adenocarcinoma; Animals; Azacitidine; Base Composition; Base Sequence; Cattle; Cells, Cultured; CpG Islands; Cytosine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Drosophila; Enzyme Inhibitors; Gene Expression Regulation; Humans; Molecular Sequence Data; Pancreatic Neoplasms; Promoter Regions, Genetic; Receptors, G-Protein-Coupled; Receptors, Gastrointestinal Hormone; Regulatory Sequences, Nucleic Acid; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors	2004
Expression of the p16INK4a gene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Molecular carcinogenesis, 2004, Volume: 39, Issue:1 Topics: Adenocarcinoma; Animals; Azacitidine; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Fibroblasts; Gene Silencing; Histiocytoma, Benign Fibrous; Lung Neoplasms; Neoplasms; Osteosarcoma; Promoter Regions, Genetic; Rats; RNA, Messenger; Sulfites; TATA Box; Tumor Cells, Cultured	2004
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Apr-01, Volume: 10, Issue:7 Topics: Adenocarcinoma; Alleles; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Separation; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; DNA Mutational Analysis; DNA, Complementary; Exons; Flow Cytometry; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Oxidoreductases; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Suppressor Proteins; WW Domain-Containing Oxidoreductase	2004
Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer research, 2004, Aug-01, Volume: 64, Issue:15 Topics: Adenocarcinoma; Apoptosis; Azacitidine; Cell Hypoxia; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Glucose Transport Proteins, Facilitative; Humans; Insulin-Like Growth Factor Binding Protein 3; Membrane Proteins; Monosaccharide Transport Proteins; Pancreas; Pancreatic Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins; Tumor Cells, Cultured	2004
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene, 2005, Jan-27, Volume: 24, Issue:5 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Decitabine; DNA Primers; Glycoproteins; Humans; Hydroxamic Acids; Loss of Heterozygosity; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous	2005
Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine. Clinical & experimental metastasis, 2004, Volume: 21, Issue:5 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; CpG Islands; Decitabine; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Stomach Neoplasms; Tumor Cells, Cultured	2004
Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. Journal of human genetics, 2005, Volume: 50, Issue:4 Topics: Acetylation; Adenocarcinoma; Azacitidine; Base Sequence; Carcinoma, Pancreatic Ductal; Cell Differentiation; CpG Islands; DNA Methylation; Dual Specificity Phosphatase 6; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Molecular Sequence Data; Neoplasm Invasiveness; Pancreatic Neoplasms; Protein Tyrosine Phosphatases; Tumor Cells, Cultured	2005
Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer biology & therapy, 2005, Volume: 4, Issue:7 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Carrier Proteins; Decitabine; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Membrane Glycoproteins; Pancreas; Pancreatic Ducts; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2005
Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecologic oncology, 2005, Volume: 99, Issue:1 Topics: Adenocarcinoma; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Endometrial Neoplasms; Enzyme Inhibitors; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Polymerase Chain Reaction; Receptors, Progesterone; RNA, Messenger; Up-Regulation	2005
DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer, 2005, Oct-15, Volume: 104, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azacitidine; Carcinoma, Adenosquamous; DNA Methylation; Female; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Intestinal Neoplasms; Male; Membrane Proteins; Metaplasia; Middle Aged; Promoter Regions, Genetic; Receptors, Retinoic Acid; Retinoids; Retinol-Binding Proteins; Retinol-Binding Proteins, Cellular; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Transcription, Genetic; Tumor Cells, Cultured	2005
Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene, 2006, May-18, Volume: 25, Issue:21 Topics: Adenocarcinoma; Azacitidine; Barrett Esophagus; beta Catenin; Cell Division; Cell Line, Tumor; CpG Islands; Decitabine; Disease Progression; DNA Methylation; DNA, Neoplasm; Esophageal Neoplasms; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, APC; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mucous Membrane; Neoplasm Proteins; Precancerous Conditions; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Transfection; Wnt Proteins; Wnt2 Protein	2006
Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features. Cancer science, 2006, Volume: 97, Issue:11 Topics: Adenocarcinoma; Adenoma; Azacitidine; CpG Islands; DNA Methylation; DNA, Neoplasm; Gallbladder Neoplasms; Humans; Immunoenzyme Techniques; Microdissection; Neoplasm Invasiveness; Neoplasm Staging; Polymerase Chain Reaction; Promoter Regions, Genetic; Tissue Array Analysis; Tumor Cells, Cultured; Ubiquitin Thiolesterase	2006
Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. International journal of cancer, 2007, Jan-01, Volume: 120, Issue:1 Topics: Adenocarcinoma; Azacitidine; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Colony-Forming Units Assay; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nasopharynx; Polymerase Chain Reaction; Promoter Regions, Genetic; Proteins; Tumor Cells, Cultured; Tumor Suppressor Proteins	2007
Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer. Journal of molecular medicine (Berlin, Germany), 2006, Volume: 84, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclin D2; Cyclins; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic	2006
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Oncogene, 2007, Apr-19, Volume: 26, Issue:18 Topics: Acetylation; Adenocarcinoma; Azacitidine; Biomarkers, Tumor; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chromatin Immunoprecipitation; Colony-Forming Units Assay; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2007
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Nov-15, Volume: 12, Issue:22 Topics: Adenocarcinoma; Aged; Azacitidine; Barrett Esophagus; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Line, Tumor; Decitabine; Disease Progression; DNA Methylation; Esophageal Diseases; Esophageal Neoplasms; Female; Genetic Markers; Glycoproteins; Humans; Male; Middle Aged; Polymerase Chain Reaction; Precancerous Conditions	2006
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS medicine, 2006, Volume: 3, Issue:12 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azacitidine; Breast Neoplasms; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cathepsin K; Cathepsins; Colonic Neoplasms; CpG Islands; Cyclin A; Cyclin A1; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Epigenesis, Genetic; Female; Gene Expression Profiling; Humans; Lung Neoplasms; Male; Middle Aged; MSX1 Transcription Factor; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostatic Neoplasms; Transcription Factors; Tumor Cells, Cultured	2006
Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers. Annals of surgical oncology, 2007, Volume: 14, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; CpG Islands; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lung Neoplasms; Male; Middle Aged; Promoter Regions, Genetic; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	2007
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. The Journal of pathology, 2007, Volume: 211, Issue:4 Topics: Adenocarcinoma; Apoptosis; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; DNA, Neoplasm; Epithelial Cells; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Proteins; Lung; Lung Neoplasms; Microarray Analysis; Neoplasm Staging; Transfection; Tumor Suppressor Proteins	2007
Potential target antigens for immunotherapy in human pancreatic cancer. Cancer letters, 2007, Jul-18, Volume: 252, Issue:2 Topics: Adenocarcinoma; Antigens, Neoplasm; Azacitidine; Base Sequence; DNA Primers; Humans; Immunotherapy; Pancreatic Neoplasms	2007
5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Apr-01, Volume: 13, Issue:7 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azacitidine; Castration; Combined Modality Therapy; Decitabine; Disease Models, Animal; Male; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Prostatic Neoplasms	2007
[Effect of adenomatous polyposis coli(APC) promoter methylation on gene transcription in lung cancer cell lines]. Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:6 Topics: Adenocarcinoma; Adenomatous Polyposis Coli Protein; Azacitidine; Carcinoma, Large Cell; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Genes, APC; Humans; Lung Neoplasms; Promoter Regions, Genetic; Small Cell Lung Carcinoma; Transcription, Genetic	2007
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy. Journal of molecular medicine (Berlin, Germany), 2007, Volume: 85, Issue:10 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Damage; DNA Methylation; DNA Methyltransferase 3B; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; RNA, Small Interfering; Stomach Neoplasms; Transfection	2007
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma. The Prostate, 2007, Sep-15, Volume: 67, Issue:13 Topics: Adenocarcinoma; Aged; Azacitidine; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 7; Decitabine; DNA Methylation; Enzyme Inhibitors; Estrogen Receptor beta; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Statistics, Nonparametric; Steroid Hydroxylases	2007
Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. International journal of oncology, 2007, Volume: 31, Issue:4 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Cell Cycle Proteins; DNA Methylation; DNA, Neoplasm; Drug Tolerance; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; RNA, Small Interfering; Taxoids; Tumor Cells, Cultured; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms	2007
Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. British journal of cancer, 2007, Oct-08, Volume: 97, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; DNA Methylation; DNA Primers; Epigenesis, Genetic; Eye Proteins; Flow Cytometry; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Nude; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stomach Neoplasms	2007
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor]. Zhonghua yi xue za zhi, 2007, Jul-24, Volume: 87, Issue:28 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoma; Adult; Aged; Azacitidine; Cell Line, Tumor; Colorectal Neoplasms; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; HCT116 Cells; Humans; Hydroxamic Acids; Intestinal Mucosa; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2007
The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. The American journal of pathology, 2007, Volume: 171, Issue:5 Topics: Adenocarcinoma; Azacitidine; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 18; Colorectal Neoplasms; Cyclins; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Loss of Heterozygosity; Mutation; Phosphoproteins; Promoter Regions, Genetic	2007
Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Cancer research, 2008, Apr-01, Volume: 68, Issue:7 Topics: Adenocarcinoma; Animals; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Rats; Rats, Inbred F344; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Up-Regulation	2008
[Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:11 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenoma; Adult; Aged; Azacitidine; Biomarkers, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Decitabine; DNA Methylation; DNA Modification Methylases; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; HCT116 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Male; Membrane Proteins; Middle Aged; RNA, Messenger	2007
Progressive silencing of p14ARF in oesophageal adenocarcinoma. Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Barrett Esophagus; Base Sequence; Cell Line; Decitabine; Disease Progression; Epithelial Cells; Esophageal Neoplasms; Female; Gene Silencing; Histones; Humans; Male; Methylation; Middle Aged; Molecular Sequence Data; Survival Rate; Tumor Suppressor Protein p14ARF	2009
Sequential combination of pyrazofurin and 5-azacytidine in patients with acute myelocytic leukemia and carcinoma. Oncology, 1981, Volume: 38, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Amides; Azacitidine; Carcinoma; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Pyrazoles; Ribonucleosides; Ribose	1981
5-Aza-2'-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:3 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Cell Division; Decitabine; Endocytosis; ErbB Receptors; Humans; KB Cells; Tumor Cells, Cultured; Up-Regulation	1994
The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity. Cancer research, 1995, Nov-15, Volume: 55, Issue:22 Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Cisplatin; DNA Damage; Drug Resistance; Female; Humans; Keratins; Ovarian Neoplasms; Tumor Cells, Cultured	1995
Evaluation of the antineoplastic activity of adozelesin alone and in combination with 5-aza-2'-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells. Anti-cancer drugs, 1993, Volume: 4, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzofurans; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Cyclohexanecarboxylic Acids; Cyclohexenes; Cytarabine; Decitabine; DNA, Neoplasm; Drug Screening Assays, Antitumor; Duocarmycins; Humans; Indoles; Lung Neoplasms; Time Factors; Tumor Cells, Cultured	1993
Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells. Anti-cancer drugs, 1997, Volume: 8, Issue:1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Blotting, Northern; Blotting, Southern; Cell Line; Colonic Neoplasms; Decitabine; DNA Methylation; Exons; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Receptors, Retinoic Acid; Tretinoin; Tumor Stem Cell Assay	1997
Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Cancer, 1997, Nov-15, Volume: 80, Issue:10 Topics: Adenocarcinoma; Azacitidine; Carrier Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; DNA Mutational Analysis; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Proteins	1997
5-Azacytidine modulates gamma-glutamyltransferase and glutathione levels in two human prostatic adenocarcinoma cell lines. Biochemistry and molecular biology international, 1998, Volume: 46, Issue:2 Topics: Adenocarcinoma; Azacitidine; Blotting, Southern; DNA Methylation; DNA, Neoplasm; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Liver; Male; Placenta; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1998
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10 Topics: Adenocarcinoma; Animals; Azacitidine; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; Gene Expression Regulation, Neoplastic; Genes, p16; Genes, Retinoblastoma; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Prostatic Hyperplasia; Prostatic Neoplasms; Retinoblastoma Protein; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured	1997
Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anti-cancer drugs, 1998, Volume: 9, Issue:9 Topics: 5-Methylcytosine; Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Colonic Neoplasms; CpG Islands; Cytosine; Decitabine; DNA Methylation; DNA Primers; DNA, Neoplasm; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptors, Retinoic Acid; Tumor Cells, Cultured	1998
Differential expression of MHC class II genes in lung tumour cell lines. European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics, 1998, Volume: 25, Issue:6 Topics: Actins; Adenocarcinoma; Antibodies, Monoclonal; Azacitidine; Blotting, Northern; Carcinoma, Large Cell; Carcinoma, Squamous Cell; Decitabine; Densitometry; Enzyme Inhibitors; Fluorescent Antibody Technique; Gene Expression; Genes, MHC Class II; Genes, myc; HLA-DP Antigens; HLA-DQ Antigens; HLA-DR Antigens; Humans; Interferon-gamma; Lung Neoplasms; Proto-Oncogene Mas; RNA, Messenger; Tumor Cells, Cultured	1998
Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clinical & experimental metastasis, 1998, Volume: 16, Issue:5 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Colonic Neoplasms; Decitabine; DNA Methylation; Gene Expression Regulation; HT29 Cells; Humans; Neoplasm Metastasis; S100 Calcium-Binding Protein A4; S100 Proteins; Transcriptional Activation; Tumor Cells, Cultured	1998
Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:5 Topics: Adenocarcinoma; Alleles; Azacitidine; Culture Media, Serum-Free; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Decitabine; DNA-Binding Proteins; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genomic Imprinting; HL-60 Cells; Humans; Mutation; Nuclear Proteins; Polymorphism, Single-Stranded Conformational; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; U937 Cells	2000
Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. International journal of cancer, 2000, Jul-15, Volume: 87, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Northern; Blotting, Southern; Carrier Proteins; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Down-Regulation; Female; Humans; Immunohistochemistry; Male; Middle Aged; Models, Genetic; Mutagens; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Stomach Neoplasms; Sulfites; Tumor Cells, Cultured	2000
Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells. Oncogene, 2000, Aug-17, Volume: 19, Issue:35 Topics: Adenocarcinoma; Azacitidine; Base Sequence; Breast Neoplasms; Clone Cells; CpG Islands; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Reporter; Humans; Molecular Sequence Data; Neoplasm Proteins; Promoter Regions, Genetic; Receptors, Retinoic Acid; Sequence Analysis, DNA; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured	2000
Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines. Carcinogenesis, 2000, Volume: 21, Issue:9 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azacitidine; Carrier Proteins; Cell Division; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; DNA Modification Methylases; DNA Mutational Analysis; DNA, Neoplasm; Female; Gene Expression; Genes, Tumor Suppressor; Immunohistochemistry; Loss of Heterozygosity; Lung Neoplasms; Mice; Mice, Inbred A; Mice, Inbred C3H; Mice, Inbred C57BL; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2000
Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. Cancer research, 2000, Aug-15, Volume: 60, Issue:16 Topics: 14-3-3 Proteins; Adenocarcinoma; Alleles; Animals; Azacitidine; Biomarkers, Tumor; Cell Cycle; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Exonucleases; Exoribonucleases; Fluorescence; G2 Phase; Gene Expression; Gene Silencing; Genes, p53; Humans; Mice; Mice, SCID; Neoplasm Proteins; Neoplasm Transplantation; Nucleic Acid Conformation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Protein Biosynthesis; Proteins; Stomach Neoplasms; Sulfites; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2000
Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency. Oncogene, 2000, Sep-21, Volume: 19, Issue:40 Topics: Activin Receptors, Type I; Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Colonic Neoplasms; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Recombinant Fusion Proteins; Sp1 Transcription Factor; Transcriptional Activation; Transfection; Tumor Cells, Cultured	2000
Induction of MAGE-3 expression in lung and esophageal cancer cells. The Annals of thoracic surgery, 2001, Volume: 71, Issue:1 Topics: Adenocarcinoma; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antigens, Neoplasm; Azacitidine; Carcinoma, Non-Small-Cell Lung; Decitabine; Depsipeptides; DNA Modification Methylases; Enzyme Inhibitors; Esophageal Neoplasms; Histone Deacetylase Inhibitors; Humans; Immunohistochemistry; Lung Neoplasms; Melanoma; Neoplasm Proteins; Peptides, Cyclic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2001
Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:9 Topics: Adenocarcinoma; Antigens, CD; Azacitidine; Base Sequence; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Kangai-1 Protein; Male; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Metastasis; Neoplasm Proteins; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Proto-Oncogene Proteins; Sulfites; Tumor Cells, Cultured	2001
Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Azacitidine; Chi-Square Distribution; Colorectal Neoplasms; Decitabine; Female; Humans; Immunohistochemistry; In Situ Hybridization; Intestinal Mucosa; Lymphatic Metastasis; Male; Membrane Glycoproteins; Methylation; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Proteoglycans; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Syndecan-1; Syndecans; Tumor Cells, Cultured	2001
Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Oncogene, 2001, Oct-25, Volume: 20, Issue:48 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Azacitidine; Binding Sites; Carrier Proteins; CCAAT-Binding Factor; Colorectal Neoplasms; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Reporter; Humans; Luciferases; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Promoter Regions, Genetic; Protein Binding; Recombinant Fusion Proteins; Transcription, Genetic; Transfection; Tumor Cells, Cultured	2001
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. British journal of cancer, 2001, Nov-02, Volume: 85, Issue:9 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; DNA Primers; DNA, Neoplasm; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Loss of Heterozygosity; Methylation; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Prognosis; RNA, Messenger; Survival Analysis; Tumor Cells, Cultured	2001
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer research, 2001, Dec-01, Volume: 61, Issue:23 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; CpG Islands; Cyclin G; Cyclin G1; Cyclins; DNA Methylation; Enkephalins; Humans; Microsatellite Repeats; Middle Aged; Pancreatic Neoplasms; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction	2001
Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo. Cancer research, 1992, Apr-15, Volume: 52, Issue:8 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Colorectal Neoplasms; Decitabine; DNA Topoisomerases, Type I; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Lethal Dose 50; Methylation; Mice; Mice, Inbred BALB C; Topotecan; Tumor Cells, Cultured	1992
Absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line. Biochimica et biophysica acta, 1992, Jul-07, Volume: 1139, Issue:3 Topics: Adenocarcinoma; Animals; Azacitidine; Cell Cycle; Colonic Neoplasms; Guanine; Humans; Mice; Mutation; Neoplasm Transplantation; Pentosyltransferases; Rhabdomyosarcoma; RNA Processing, Post-Transcriptional; RNA, Transfer; Tumor Cells, Cultured	1992
Outgrowth of stable class I major histocompatibility complex-expressing subsets from immunogenic variants of a murine mammary carcinoma: association with a differentially staining region on chromosome 9. Genes, chromosomes & cancer, 1991, Volume: 3, Issue:6 Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Azacitidine; Biomarkers, Tumor; Chromosome Mapping; Clone Cells; Female; Genetic Markers; Graft Rejection; H-2 Antigens; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred CBA; Mice, Nude; Neoplasm Transplantation; Phenotype	1991
Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells. International journal of radiation oncology, biology, physics, 1987, Volume: 13, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Butyrates; Butyric Acid; Cells, Cultured; Colon; Colonic Neoplasms; Decitabine; Humans; Radiation-Sensitizing Agents	1987
5-Azacytidine induction of stable myoepithelial and acinar cells from a human salivary intercalated duct cell clone. Cancer research, 1987, Aug-15, Volume: 47, Issue:16 Topics: Adenocarcinoma; Amylases; Animals; Azacitidine; Cell Differentiation; Clone Cells; DNA; Humans; Methylation; Mice; Mice, Inbred BALB C; Myosins; Neoplasm Transplantation; Salivary Gland Neoplasms; Transplantation, Heterologous	1987
In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma. Cancer research, 1987, Sep-15, Volume: 47, Issue:18 Topics: Adenocarcinoma; Animals; Azacitidine; Decitabine; Female; Graft Rejection; Histocompatibility Antigens; Histocompatibility Antigens Class II; Mammary Neoplasms, Experimental; Methylnitronitrosoguanidine; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Neoplasm Transplantation	1987